Pancreatic Endocrine Tumor Therapeutic Pipeline Review H2 2014

1
Pancreatic Endocrine Tumor Pipeline Review, H2
2014 By RnRMarketResearch

• Browse more reports on Pharmaceuticals at
  http//www.rnrmarketresearch.com/reports/life-scie
  nces/pharmaceuticals

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
2
Pancreatic Endocrine Tumor Pipeline Review, H2
2014

• Global Markets Directs, Pancreatic Endocrine
  Tumor Pipeline Review, H2 2014', provides an
  overview of the Pancreatic Endocrine Tumors
  therapeutic pipeline.
• This report provides comprehensive information on
  the therapeutic development for Pancreatic
  Endocrine Tumor, complete with comparative
  analysis at various stages, therapeutics
  assessment by drug target, mechanism of action
  (MoA), route of administration (RoA) and molecule
  type, along with latest updates, and featured
  news and press releases. It also reviews key
  players involved in the therapeutic development
  for Pancreatic Endocrine Tumor and special
  features on late-stage and discontinued projects.
•  Complete report available at http//www.rnrmarket
  research.com/pancreatic-endocrine-tumor-pipeline-r
  eview-h2-2014-market-report.html .

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
3
Pancreatic Endocrine Tumor Pipeline Review, H2
2014

• Global Markets Directs report features
  investigational drugs from across globe covering
  over 20 therapy areas and nearly 3,000
  indications. The report is built using data and
  information sourced from Global Markets Directs
  proprietary databases, Company/University
  websites, SEC filings, investor presentations and
  featured press releases from company/university
  sites and industry-specific third party sources,
  put together by Global Markets Directs team.
  Drug profiles/records featured in the report
  undergoes periodic updation following a stringent
  set of processes that ensures that all the
  profiles are updated with the latest set of
  information.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
4
Pancreatic Endocrine Tumor Pipeline Review, H2
2014

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Pancreatic Endocrine
  Tumor.
• The report reviews key pipeline products under
  drug profile section which includes product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities.
• The report reviews key players involved in the
  therapeutics development for Pancreatic Endocrine
  Tumor and enlists all their major and minor
  projects.
• The report summarizes all the dormant and
  discontinued pipeline projects.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
5
Pancreatic Endocrine Tumor Pipeline Review, H2
2014

• Reasons to Buy
• Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies.
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage.
• Develop strategic initiatives by understanding
  the focus areas of leading companies.
• Identify and understand important and diverse
  types of therapeutics under development for
  Pancreatic Endocrine Tumor.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
6
Pancreatic Endocrine Tumor Pipeline Review, H2
2014

• For more details contact Mr. Ritesh Tiwari
  sales_at_rnrmarketresearch.com / 18883915441

RnRMarkertResearch RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR Market Research library has
syndicated reports by leading market research 
publishers across the globe.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441